Exelixis, Inc. (EXEL)

NASDAQ: EXEL · USD

$66.3

+0.95 (+1.4%)· Recorded snapshot

Market cap	16.4B
Revenue (ttm)	2.4B
Net income (ttm)	860.6M
EPS (ttm)	$3.19
Shares out	247.8M
P/E (trailing)	20.8x
P/E (forward)	18.8x
Volume	1,315,505
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.4B
Net income (ttm): 860.6M
EPS (ttm): $3.19
P/E (trailing): 20.8x
P/E (forward): 18.8x
Market cap: 16.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.8

P25 n/aP50 n/aP75 n/a

Trailing P/E20.8

P25 n/aP50 n/aP75 n/a

ROE44.4

P25 n/aP50 n/aP75 n/a

ROIC66

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EXEL indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000939767
Company name	Exelixis, Inc.
Country	United States
Country code	US
CUSIP number	30161Q104
Earnings date	2026-10-29
Earnings time	amc
Employees	1,077
Employees change	-70
Employees growth	-6.1%
Enterprise value	$15.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1994
Industry	Biotechnology
IPO date	2000-04-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US30161Q1040
Last 10-K release date	2026-02-10
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$16.4B
Market cap category	Large-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$66.30
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	EXEL
U.S. state	California
Website	https://www.exelixis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	18.94x
Average P/E ratio (10Y)	60.9x
Average P/E ratio (3Y)	24.67x
Average P/E ratio (5Y)	26.7x
Earnings yield	4.81%
EV/Earnings	17.6x
EV/EBIT	15.27x
EV/EBITDA	14.85x
EV/FCF	12.92x
EV/Sales	6.22x
FCF / EV yield	7.74%
FCF yield	7.16%
Forward EV/Sales	5.63x
Forward P/E	18.83x
Forward P/S	6.08x
Graham number	23.0434
Graham upside	-65.12%
Lynch fair value	$79.64
Lynch upside	20.56%
P/(FCF - SBC) ratio	15.44x
P/(OCF - SBC) ratio	15.29x
P/B ratio	8.82x
P/E ratio	20.81x
P/FCF ratio	13.96x
P/OCF ratio	13.83x
P/S ratio	6.72x
PEG ratio	1.67x
Price / tangible book value	9.2x
Price/EBITDA ratio	16.04x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	40.72%
EBITDA margin	41.89%
Effective tax rate	16.89%
FCF margin	48.13%
Gross margin	96.48%
Operating margin	40.72%
Pretax margin	42.51%
Profit margin	35.33%
Profit per employee	$799,093
Profitable quarters	14
Profitable years	9
Revenue per employee	$2.3M
ROA	23.97%
ROA (5Y)	9.89%
ROCE	46.52%
ROE	44.39%
ROE (5Y)	17.29%
ROIC	66%
ROIC (5Y)	29.34%
SBC / revenue	4.62%
Tax / revenue	7.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	53.41%
EPS growth (Q)	26.15%
EPS growth (QoQ)	3.8%
EPS growth 3Y	85.25%
EPS growth 5Y	61.2%
EPS growth quarters	4
EPS growth years	3
FCF growth	55.49%
FCF growth (Q)	551.99%
FCF growth (QoQ)	20.21%
FCF growth 3Y	48.72%
FCF growth 5Y	39.99%
Gross profit growth	9.11%
Gross profit growth (Q)	10.8%
Gross profit growth 3Y	12.49%
Gross profit growth 5Y	16.17%
Net income growth	42.89%
Net income growth (Q)	14.72%
Net income growth (QoQ)	0.75%
Net income growth 3Y	73.69%
Net income growth 5Y	55.7%
Net income growth quarters	4
Net income growth years	3
OCF growth	53.29%
OCF growth (Q)	528.13%
OCF growth (QoQ)	22.19%
OCF growth 10Y	34.43%
OCF growth 3Y	44.88%
OCF growth 5Y	34.16%
Operating income growth	31.96%
Operating income growth (Q)	16.31%
Operating income growth 3Y	91.52%
Operating income growth 5Y	58.2%
Revenue growth	9.23%
Revenue growth (Q)	10.63%
Revenue growth (QoQ)	2.93%
Revenue growth 10Y	42.32%
Revenue growth 3Y	12.42%
Revenue growth 5Y	16.06%
Revenue growth quarters	4
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-11M
Depreciation and amortization	$28.3M
EBIT	$992M
EBITDA	$1B
EPS	$3.19
FCF per share	$4.73
Financing cash flow	$-1.2B
Free cash flow	$1.2B
Free cash flow minus SBC	$1.1B
Gross profit	$2.4B
Income taxes	$174.8M
Investing cash flow	$93M
Net cash flow	$117M
Net income	$860.6M
Operating cash flow minus SBC	$1.1B
Operating income	$992M
Revenue	$2.4B
Stock-based compensation	$112.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	13.09
Book value per share	$7.41
Debt / EBITDA	0.16
Debt / equity	0.09
Debt / FCF	0.14
Goodwill	$63.7M
Long-term assets	$1.2B
Long-term liabilities	$288.5M
Net cash (debt)	$1.2B
Net cash / market cap	7.44%
Net cash growth	1.03%
Net debt / EBITDA	-1.19
Net debt / equity	-0.66
Net debt / FCF	-1.04
Piotroski F-Score	5
Property, plant and equipment	$305.2M
Shareholders' equity	$1.8B
Tangible book value	$1.8B
Tangible book value per share	$7.15
Total assets	$2.5B
Total cash	$839.4M
Total debt	$165.9M
Total liabilities	$650.5M
WACC	6.75%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.94
Current assets	$1.3B
Current liabilities	$361.9M
Current ratio	3.46
Inventory turnover	3.28
Net working capital	$49.5M
Quick ratio	3.24
Working capital	$888.9M
Working capital turnover	2.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	6.54%
Dividend yield	0%
Shareholder yield	6.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	505.45%
10Y return CAGR	19.73%
10Y total return	505.45%
150-day SMA	$53.27
15Y price change	746.54%
15Y return CAGR	15.3%
15Y total return	746.54%
1D price change	1.45%
1M price change	13.68%
1M total return	13.68%
1W price change	2.68%
1W total return	2.68%
1Y price change	65.33%
1Y return CAGR	65.39%
1Y total return	65.33%
20-day SMA	$61.71
200-day SMA	$50.68
20Y price change	569.18%
20Y return CAGR	9.97%
20Y total return	569.18%
3M price change	18.46%
3M total return	18.46%
3Y price change	227.3%
3Y return CAGR	48.46%
3Y total return	227.3%
50-day SMA	$58.83
50-day SMA vs 200-day SMA	50over200
52-week high	$66.38
52-week high date	2026-10-28
52-week low	$36.00
52-week low date	2025-11-03
5Y price change	210.4%
5Y return CAGR	25.43%
5Y total return	210.4%
6M price change	48.07%
6M total return	48.07%
All-time high	$66.38
All-time high date	2026-10-28
All-time low	$1.26
All-time low date	2014-12-23
Average true range (ATR)	$1.51
Average volume	2.2M
Beta (1Y)	0.27
Beta (2Y)	0.91
Beta (5Y)	0.47
Change from 52-week high	-0.13%
Change from 52-week low	84.15%
Change from all-time high	-0.4%
Change from all-time low	5,147.22%
Change from open	2.23%
Day's gap	-0.77%
Dollar volume	$87.2M
High price	$66.35
Low price	$64.85
Monthly RSI	78.63
Open price	$64.85
Position in 52-week range	96.33%
Premarket change	0.23%
Premarket close	$65.35
Premarket price	$65.50
Premarket volume	13.5K
Previous close	$65.35
Price vs 150-day SMA	24.12%
Price vs 20-day SMA	7.13%
Price vs 200-day SMA	30.46%
Price vs 50-day SMA	12.38%
Relative volume	0.61
RSI	75.13
Sharpe ratio	1.54
Sharpe ratio (3Y)	1.19
Sharpe ratio (5Y)	0.69
Sortino ratio	2.64
Sortino ratio (3Y)	2.02
Sortino ratio (5Y)	1.18
Volume	1.3M
Weekly RSI	75.5
YTD price change	50.84%
YTD total return	50.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	213.6M
Float percentage	86.21%
Shares change (QoQ)	-2.86%
Shares change (YoY)	-6.54%
Shares held by insiders	2.63%
Shares held by institutions	95.23%
Shares outstanding	247.8M
Short % of float	12.79%
Short % of shares	11.02%
Short ratio	12.7 days

Deeper analysis on EXEL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EXEL report

Is a complete EXEL research report available?

No complete published report is available for Exelixis, Inc. (EXEL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Exelixis, Inc. (EXEL)

Price

Financial snapshot

Fair-value bridge

Latest news · EXEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EXEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EXEL

Frequently asked questions